Galacto-Oligosaccharide RP-G28 Improves Multiple Clinical Outcomes in Lactose-Intolerant Patients

por Chey, William, Sandborn, William, Ritter, Andrew J., Foyt, Howard, Azcarate-Peril, M. Andrea, Savaiano, Dennis A.
Publicado 2020

A double-blind, 377-subject randomized study identifies Ruminococcus, Coprococcus, Christensenella, and Collinsella as long-term potential key players in the modulation of the gut...

por Azcarate-Peril, M. A., Roach, J., Marsh, A., Chey, William D., Sandborn, William J., Ritter, Andrew J., Savaiano, Dennis A., Klaenhammer, T. R.
Publicado 2021

Improving lactose digestion and symptoms of lactose intolerance with a novel galacto-oligosaccharide (RP-G28): a randomized, double-blind clinical trial

por Savaiano, Dennis A, Ritter, Andrew J, Klaenhammer, Todd R, James, Gareth M, Longcore, Amy T, Chandler, Justin R, Walker, W Allan, Foyt, Howard L
Publicado 2013